Although the in vitro granuloma model may not be able to capture the entire complexity of IL-17 biology, the lack of effect on M. tuberculosis dormancy reported here is in line with the absence of mycobacterial reactivation in clinical and preclinical settings. This evidence concerns the gene IL17A and Granuloma.